The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) has created the DCP Early Career Scientist Spotlight Research Seminar Series to highlight nominated early career scientists who are advancing research within the areas supported by DCP. These research areas include:
- Cancer Early Detection Biomarker Development and Screening
- Intervention Development for Cancer Prevention
- Precision Cancer Prevention
- Symptom Science and Management
Beyond their talks, the invited speakers, all DCP Early Career Scientists, will have the opportunity to interact with DCP and the broader NCI staff involved in cancer prevention research. While the overall goal is to increase visibility and provide recognition to the DCP Early Career Scientists, these research seminars alongside interactions with the cancer prevention research community at NCI will also promote the acceleration of progress and innovation of cancer prevention.
These seminars are held virtually via Webex.
Upcoming DCP Early Career Scientist Spotlight Research Seminar Series
EASTER Project Phase 1: Advancing Affordable AI-Driven Systems for Cervical Cancer Screening, Triage, and Treatment
Monday, June 16, 2025 - 3:00pm EDT to 4:00pm EDT
The DCP Early Career Scientist Spotlight Research Seminar Series highlights nominated early career scientists who are advancing research within the areas supported by DCP.
Targeting Aging Biology to Optimize the Long-Term Health of Cancer Survivors
Thursday, July 10, 2025 - 5:00pm EDT to 6:00pm EDT
The DCP Early Career Scientist Spotlight Research Seminar Series highlights nominated early career scientists who are advancing research within the areas supported by DCP.
Past DCP Early Career Scientist Spotlight Research Seminar Series
2025
Harnessing Studies of Diet and the Gut Microbiome to Reduce Colorectal Cancer Burden
Monday, May 19, 2025 - 3:00pm EDT to 4:00pm EDT
Speaker
Doratha "Armen" Byrd, Ph.D., M.P.H.
Assistant Member
Departments of Cancer Epidemiology Program and Gastrointestinal Oncology
Moffitt Cancer Center
Biography
Dr. Byrd received a B.S. in…
Personalised Risk in Lung Screening
Monday, May 12, 2025 - 3:00pm EDT to 4:00pm EDT
Speaker
Xiaoshuang Feng, Ph.D.
Scientist
Cancer Epidemiology Branch
International Agency for Research on Cancer (IARC)
World Health Organization (WHO)
Biography
I am an early-career scientist working in…
Leveraging Behavioral Medicine, Optimization Methods, and Digital Delivery to Improve Sleep Health in Cancer Survivorship
Wednesday, April 23, 2025 - 3:00pm EDT to 4:00pm EDT
Speaker
Rina S. Fox, Ph.D., M.P.H.
Assistant Professor
University of Arizona College of Nursing
Tucson, AZ
Biography
Dr. Rina S. Fox is an Assistant Professor at the University of Arizona College of…
Reprogramming Lipogenic Metabolism and Inflammation in High-risk Breast with Licochalcone A: A Novel Path to Cancer Prevention
Monday, April 21, 2025 - 5:00pm EDT to 6:00pm EDT
Speaker
Atieh Hajirahimkhan, Ph.D.
NCI NRSA Postdoctoral Fellow
Department of Surgery
Lurie Cancer Center Translational Bridge Fellow
Robert H. Lurie Comprehensive Cancer Center
Feinberg School of Medicine…
Survivorship in Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T-Cell Therapy
Wednesday, April 9, 2025 - 5:00pm EDT to 6:00pm EDT
Speaker
Laura Oswald, Ph.D.
Department of Health Outcomes and Behavior
Moffitt Cancer Center
Dr. Laura Oswald is a tenure-track Assistant Member in the Department of Health Outcomes and Behavior at Moffitt…
Linking the Macroenvironment and Microenvironment to Study Breast Cancer Etiology and Progression
Monday, March 31, 2025 - 3:00pm EDT to 4:00pm EDT
Speaker
Alexandra Harris, Ph.D., M.P.H.
Cancer Prevention Fellow, NCI, NIH
Biography
Dr. Alexandra R. Harris is a postdoctoral fellow and transdisciplinary breast cancer researcher at the National Cancer…
Engineering Orthogonal Breath Biomarkers for Multiplexed Cancer Diagnostics
Monday, March 3, 2025 - 4:00pm EST to 5:00pm EST
Speaker
Shih-Ting "Christine" Wang, Ph.D.
Assistant Professor, Department of Material Science and Engineering, Northwestern University
Biography
Dr. Christine Wang is a biomaterials engineer specializing…
2024
Exploring Chemoprevention Strategies for Bladder Cancer Interception
Monday, July 29, 2024 - 3:00pm EDT to 4:00pm EDT
Bladder cancer (BC) is one of the most frequently diagnosed neoplasms, with an estimated half a million new cases and 200,000 deaths per year worldwide. Men have a 3-4 times higher risk of developing bladder cancer than women.
Feasibility of Self-Administered, Intravaginal Therapies for Cervical Precancer Treatment in Low- and Middle-Income Countries
Wednesday, May 29, 2024 - 4:00pm EDT to 5:00pm EDT
In 2020, cervical cancer resulted in over 600,000 deaths worldwide, despite being largely preventable through vaccination and screening. The disease primarily impacts women in low- and middle-income countries (LMICs), who represent 85% of the cases and 90% of the deaths.
CD8+ T Cell Clonal Dynamics in Response to ICB Therapy in Surgically Resectable (Sx) NSCLC
Friday, April 19, 2024 - 3:00pm EDT to 4:00pm EDT
Metastasis is the primary cause of mortality in surgically resectable (Sx) non-small cell lung cancer (NSCLC), with early detection advancements failing to curb metastatic recurrence.
The Role of Neoantigen-Specific T-Cells in Cancer Interception and Immune Monitoring of Lynch Syndrome
Friday, March 22, 2024 - 4:00pm EDT to 5:00pm EDT
Lynch Syndrome (LS) is a hereditary condition marked by mutations in mismatch repair genes, leading to a high risk of colorectal (50-80%) and endometrial (40-60%) cancers, among others.
Harnessing the Potential for Immune Interception in Pancreatic Cancer High-Risk Cohort
Monday, February 12, 2024 - 5:00pm EST to 6:00pm EST
Pancreatic ductal adenocarcinoma (PDAC) remains a deadly disease and is projected to be the third leading cause of death by 2030. Contemporary immunotherapies have shown little to now response in PDAC.
Tuning the organ-selectivity of mRNA expression through dendrimer-based lipid nanoparticles
Monday, January 29, 2024 - 5:00pm EST to 6:00pm EST
The predominant liver-targeting of lipid nanoparticles (LNPs) significantly limited the general application of IVT-mRNA as a systemic therapy. To identify novel LNPs that deliver mRNA beyond the liver, we constructed a library of ionizable lipids using dendrimer as a scaffold.
Read more about this early career opportunity!
Please email NCIDCPworkforce@mail.nih.gov if you have any questions or inquiries about this research seminar series.
Especially if:
- You want to contact a past DCP Early Career Scientist after their research talk.
- You want to be considered for a meeting with a DCP Early Career Scientist on the day of their research talk.
- You are having trouble finding when and how to attend the DCP Early Career Scientist Spotlight Research Seminar.